Farxiga (dapagliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor for managing high blood sugar in those with type 2 diabetes. Studies demonstrate that Farxiga has the potential to expedite weight loss; however, how much and how quickly vary. This article discusses Farxiga's impact...
www.verywellhealth.com